SwePub
Sök i LIBRIS databas

  Extended search

onr:"swepub:oai:DiVA.org:uu-222605"
 

Search: onr:"swepub:oai:DiVA.org:uu-222605" > The effect of the U...

  • 1 of 1
  • Previous record
  • Next record
  •    To hitlist

The effect of the UGT1A1*28 allele on survival after irinotecan-based chemotherapy : a collaborative meta-analysis

Dias, M M (author)
Pignon, J-P (author)
Karapetis, C S (author)
show more...
Boige, V (author)
Glimelius, Bengt (author)
Uppsala universitet,Enheten för onkologi
Kweekel, D M (author)
Lara, P N (author)
Laurent-Puig, P (author)
Martinez-Balibrea, E (author)
Páez, D (author)
Punt, C J A (author)
Redman, M W (author)
Toffoli, G (author)
Wadelius, Mia (author)
Uppsala universitet,Klinisk farmakogenomik och osteoporos,Clinical pharmacogenomics
McKinnon, R A (author)
Sorich, M J (author)
show less...
 (creator_code:org_t)
2014-04-08
2014
English.
In: The Pharmacogenomics Journal. - : Springer Science and Business Media LLC. - 1470-269X .- 1473-1150. ; 14:5, s. 424-431
  • Journal article (peer-reviewed)
Abstract Subject headings
Close  
  • To date, studies of irinotecan pharmacogenetics have mostly focused on the effect of the UGT1A1*28 allele on irinotecan-related toxicity. However, the clinical utility of routine UGT1A1*28 genotyping to pre-emptively adjust irinotecan dosage is dependent upon whether UGT1A1*28 also affects patient survival following irinotecan therapy. Previous observational studies evaluating the influence of UGT1A1*28 on survival have shown contradictory results. A systematic review and meta-analysis of both published and unpublished data were performed to summarize the available evidence of the relationship between the UGT1A1*28 allele and patient survival related to irinotecan therapy. Overall and progression-free survival meta-analysis data were available for 1524 patients and 1494 patients, respectively. The difference in the survival between patients of different UGT1A1*28 genotypes (homozygous, heterozygous or wild-type) who had received irinotecan was not found to be statistically significant. There was also no evidence of irinotecan dose, regimen or line of therapy having an impact on this association.

Subject headings

MEDICIN OCH HÄLSOVETENSKAP  -- Klinisk medicin -- Klinisk laboratoriemedicin (hsv//swe)
MEDICAL AND HEALTH SCIENCES  -- Clinical Medicine -- Clinical Laboratory Medicine (hsv//eng)

Publication and Content Type

ref (subject category)
art (subject category)

Find in a library

To the university's database

  • 1 of 1
  • Previous record
  • Next record
  •    To hitlist

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Close

Copy and save the link in order to return to this view